Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × IMM-101 × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 4 Gastrointestinal 2 Sarcoma 1

Conditions

Sarcoma 1 Neoplasm Metastasis 1 Melanoma 1

Interventions

Temozolomide 61 Cyclophosphamide 54 Radiotherapy 52 Bevacizumab 50 Doxorubicin 48 Ifosfamide 33 pazopanib 28 fludarabine phosphate 28 Etoposide 27 Gemcitabine 24 Radiation 23 pembrolizumab 22 Sunitinib 22 Sirolimus 22 Filgrastim 22 Irinotecan 21 Whole-Body Irradiation 20 Peripheral Blood Stem Cell Transplantation 20 Imatinib Mesylate 20 Vincristine 19 Mycophenolic Acid 19 Sorafenib 16 Methotrexate 16 Magnetic Resonance Spectroscopy 16 Busulfan 16 Melphalan 15 Carboplatin 15 Docetaxel 14 Cyclosporine 14 temsirolimus 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03009058 2024-11-25

MODULATE

Immodulon Therapeutics Ltd

Phase 1/2 Terminated

2 enrolled 7 charts

DermatologicSarcoma

Melanoma, Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡